Original Research
Published on 03 Jan 2025
FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500458
- 1,592 views
Type at least 3 characters
655 articles
Original Research
Published on 03 Jan 2025
Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485072
- 1,267 views
Original Research
Published on 18 Dec 2024
An exploratory study evaluated the 30 most commonly reported medications in the United States food and drug administration’s adverse event reporting system that are associated with the occurrence of kidney stones
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377679
- 2,391 views
Original Research
Published on 18 Dec 2024
Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493166
- 1,019 views
Original Research
Published on 18 Dec 2024
PM2.5-induced oxidative stress upregulates PLA2R expression in the lung and is involved in the pathogenesis of membranous nephropathy through extracellular vesicles
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516111
- 1,460 views
- 2 citations
Original Research
Published on 16 Dec 2024
Ondansetron use is associated with increased risk of acute kidney injury in ICU patients following cardiac surgery: a retrospective cohort study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1511545
- 2,086 views
Original Research
Published on 12 Dec 2024
JiangyaTongluo decoction ameliorates tubulointerstitial fibrosis via regulating the SIRT1/PGC-1α/mitophagy axis in hypertensive nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491315
- 2,457 views
- 1 citation
Correction
Published on 12 Dec 2024
Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1532797
- 640 views
Editorial
Published on 11 Dec 2024
Editorial: Novel pathophysiologic mechanisms and reno-protective pharmacotherapies in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1531748
- 981 views
Original Research
Published on 11 Dec 2024
Hypoalbuminemia and cisplatin-induced acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510477
- 1,146 views
Systematic Review
Published on 11 Dec 2024
Safety of ACEI/ARB use in the early (<3 months) post kidney transplant period: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1522558
- 1,128 views
Systematic Review
Published on 06 Dec 2024
Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476587
- 1,717 views
Retraction
Published on 05 Dec 2024
Retraction: CXCL6 promotes renal interstitial fibrosis in diabetic nephropathy by activating JAK/STAT3 signaling pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1530358
- 933 views
Original Research
Published on 04 Dec 2024
Calcium sensing receptor regulate claudin-14 via PKA-STAT3 pathway in rat model of nephrolithiasis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477122
- 1,425 views
- 1 citation
Review
Published on 02 Dec 2024
Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403227
- 2,510 views
- 2 citations
Original Research
Published on 02 Dec 2024
Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499012
- 1,643 views
- 1 citation